Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Caterina Casari et al, published in Haematologica:
“This is an excellent review of von Willebrand disease and its therapeutic landscape by three respected experts. It begins with the history of early discoveries and ends with an assessment of the range of new therapeutic advances that offer much hope for a sustainable prophylaxis that will greatly enhance the quality of life of patients.
For me, it is good to see highlighted such pioneers as Judith Poole (Stanford Univ, USA), Theodore Zimmerman (Scripps Clinic, USA), Birger and Margareta Blomback (Karolinska Institute, Sweden), Pïer Mannuccio Mannucci (Milan, Italy) happily still active, and the sadly missed J Evan Saddler (St. Louis, USA); and which extends through to a new generation such as Cécile Denis and Peter Lenting from France to name but two.
This review is highly recommended.”
Title: Historical, current and future treatments for von Willebrand disease
Authors: Caterina Casari, Frank W.G. Leebeek, Flora Peyvandi
Read the Full Article on Haematologica.

Other articles featuring Alan Nurden on Hemostasis Today.
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?